Benjamin Wolin
CIK 1492650 · President and CEO · last filed 2022-10-13
Benjamin Wolin is a President and CEO who has filed 58 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CVET, was dated Oct 13, 2022. Across all open-market trades the lifetime net is −$3.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVET price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
345 HUDSON STREET, 16TH FLOOR
NEW YORK, NY 10014
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COVETRUS, INC. (CVET) Delisted | President and CEO | 0 | $20.99 | $0 | -$3.45M | 36 | 2022-10-13 |
| Diplomat Pharmacy, Inc. (DPLO) Delisted | Director | 0 | — | — | -$51.1K | 9 | 2020-02-10 |
| RMTI | Director | 252 | $7.00 | $1.8K | $0 | 2 | 2019-06-10 |
| Everyday Health, Inc. (EVDY) Delisted | CEO | 168,172 | — | — | $10.0K | 11 | 2016-12-06 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-13 | COVETRUS, INC. (CVET) Delisted | Disp (D) | −198,711 | $0 | EDGAR |
| 2022-09-06 | COVETRUS, INC. (CVET) Delisted | Mixed | +4,223 | -$68.8K | EDGAR |
| 2022-08-11 | COVETRUS, INC. (CVET) Delisted | Sell (S) | −10,584 | -$220.3K | EDGAR |
| 2022-07-25 | COVETRUS, INC. (CVET) Delisted | Mixed | +12,126 | -$196.3K | EDGAR |
| 2022-07-14 | COVETRUS, INC. (CVET) Delisted | Sell (S) | −10,585 | -$219.3K | EDGAR |
| 2022-06-16 | COVETRUS, INC. (CVET) Delisted | Sell (S) | −10,586 | -$217.8K | EDGAR |
| 2022-06-03 | COVETRUS, INC. (CVET) Delisted | Mixed | +4,223 | -$68.3K | EDGAR |
| 2022-05-25 | COVETRUS, INC. (CVET) Delisted | Sell (S) | −41,925 | -$859.5K | EDGAR |
| 2022-04-25 | COVETRUS, INC. (CVET) Delisted | Mixed | +12,125 | -$149.4K | EDGAR |
| 2022-03-03 | COVETRUS, INC. (CVET) Delisted | Mixed | +87,448 | -$954.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.